Introducing the ACURATE Prime™ Aortic Valve System
With a split-level design, predictable commissure alignment, and unique top-down deployment, ACURATE Prime provides you with the predictable performance you want today, and the outcomes patients need for tomorrow.
Elevate your TAVI experience with ACURATE Prime.
- Expanded treatment range
- Enhanced valve frame
- Quicker, controlled deployment
- Streamlined device preparation
Open stablization arches
For unrestricted coronary access1 aided by predicable commissure alignment2
Supra-annular leaflets
Designed to provide large EOAs and low gradients3
Connected cells
Designed to allow for equally distributed radial force over circumference*
Active PVseal™ technology
360° dynamic sealing skirt to mitigate PVL4
Valve sizing
| Valve size | 23 mm | 25 mm | 27 mm | 29 mm |
|---|---|---|---|---|
| Aortic annulus diameter** | 20.5 mm - 23 mm | 22.5 mm - 25 mm | 24.5 mm - 27 mm | 26.5 mm - 29 mm |
| Aortic annulus perimeter | 64 mm - 72 mm | 71 mm - 79 mm | 77 mm - 85 mm | 83 mm - 91 mm |
Positive early clinical outcomes both at discharge and 30 days.
No deaths or disabling stroke through 30 days.
Learn more
REFERENCES
*BSC data on file. Technical Report 97090122.
**CT-based measurement: Perimeter-derived annulus.
1. Barbanti M, Costa G, Picci A, et al. Coronary Cannulation After Transcatheter Aortic Valve Replacement: The RE-ACCESS Study. JACC Cardiovasc Interv. 2020 Nov 9;13(21):2542-2555.
2. Bieliauskas G, Wong I, Bajoras V, et al. Patient-Specific Implantation Technique to Obtain Neo-Commissural Alignment With Self-Expanding Transcatheter Aortic Valves. JACC Cardiovasc Interv. 2021 October 11;14(19):2097–2108.
3. Möllmann H, Holzhey DM, Hilker M, et al. The ACURATE neo2 valve system for transcatheter aortic valve implantation: 30-day and 1-year outcomes. Clin Res Cardiol. 2021 Dec;110(12):1912-1920.
4. Kim WK, Tamburino C, Möllmann H, et al. Clinical outcomes of the ACURATE neo2 transcatheter heart valve: a prospective, multicenter, observational, post-market surveillance study. EuroIntervention. 2023 May 12;19(1):83-92.
CAUTION: The law restricts these devices to sale by or on the order of a physician. Indications, contraindications, warnings, and instructions for use can be found in the product labelling supplied with each device or at www.IFU-BSCI.com. Products shown for INFORMATION purposes only and may not be approved or for sale in certain countries. This material not intended for use in France. 2024 Copyright © Boston Scientific Corporation or its affiliates. All rights reserved.
CE 0344